These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3965216)

  • 1. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by nuclear magnetic resonance and mass spectrometry of a glucuronic acid conjugate of o-hydroxybenzoic acid in normal urine and uremic plasma.
    Monti JP; Gallice P; Crevat A; Murisasco A
    Clin Chem; 1985 Oct; 31(10):1640-3. PubMed ID: 4042329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of canine plasma components suspected as uremic toxins.
    Kawamura M; Ohashi F; Nagata Y; Takai N; Motoie H; Nishimura R; Sasaki N; Takeuchi A
    J Vet Med Sci; 1993 Apr; 55(2):265-70. PubMed ID: 8513007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
    Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two uremic toxins by nuclear magnetic resonance and mass spectrometry.
    Monti JP; Gallice P; Braguer D; Durand C; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():223-6. PubMed ID: 3447439
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of a double conjugate in uremic body fluids.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    FEBS Lett; 1981 Jul; 129(2):237-40. PubMed ID: 7286217
    [No Abstract]   [Full Text] [Related]  

  • 7. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for separation of middle molecules by high performance liquid chromatography: application in studies of glucuronyl-o-hydroxyhippurate in normal and uremic subjects.
    Zimmerman L; Bergström J; Jörnvall H
    Clin Nephrol; 1986 Feb; 25(2):94-100. PubMed ID: 3698350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of middle molecule compounds.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid derivatives in two different fractions of uremic toxins.
    Gallice PM; Monti JP; Braguer DL; Baz M; Elsen RE; Berland YF; Crevat AD
    Int J Artif Organs; 1991 Dec; 14(12):754-8. PubMed ID: 1783448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion-pair high-performance liquid chromatography profiling of a uremic toxin fraction.
    Gallice P; Monti JP; Le Gall JM; Crevat A; Murisasco A
    J Chromatogr; 1987 Nov; 422():263-6. PubMed ID: 3437013
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of an ascorbic acid metabolite among "uremic middle molecules".
    Gallice PM; Monti JP; Braguer DL; Monti HM; Elsen RE; Berland YF; Crevat AD
    Clin Chem; 1990 Jul; 36(7):1369-72. PubMed ID: 2372954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia.
    Lichtenwalner DM; Suh B; Lichtenwalner MR
    J Clin Invest; 1983 May; 71(5):1289-96. PubMed ID: 6853715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for peptidic "middle molecules" in uremic sera: isolation and chemical identification of fibrinogen fragments.
    Kaplan B; Cojocaru M; Unsworth E; Knecht A; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):141-53. PubMed ID: 14552825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle molecules and the 7 C factor.
    Bergström J; Jörnvall H; Zimmerman L
    Adv Exp Med Biol; 1987; 223():27-32. PubMed ID: 3447445
    [No Abstract]   [Full Text] [Related]  

  • 17. Ascorbic acid-2-0-beta-glucuronide, a new metabolite of vitamin C identified in human urine and uremic plasma.
    Gallice P; Sarrazin F; Polverelli M; Cadet J; Berland Y; Crevat A
    Biochim Biophys Acta; 1994 Apr; 1199(3):305-10. PubMed ID: 8161570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic toxins and the elusive middle molecules.
    Schoots A; Mikkers F; Cramers C; de Smet R; Ringoir S
    Nephron; 1984; 38(1):1-8. PubMed ID: 6472528
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of sub-peak b4.2, middle molecule.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():28-32. PubMed ID: 7295091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation, structure elucidation and synthesis of a hexapeptide from the hemodialysate of uremic patients].
    Bovermann G; Rautenstrauch H; Seybold G; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Oct; 363(10):1187-202. PubMed ID: 7141402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.